Helicobacter pylori: Phenotypes, genotypes and virulence genes

Future Microbiology

Volumn 4, Issue 2, 2009, Pages 223-240

  Proença Modena, José Luiz ^a   Acrani, Gustavo Olszanski ^a   Brocchi, Marcelo ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Genetic variability; Helicobacter pylori; Pathogenicity; Virulence factors

Indexed keywords

AMMONIA; BACTERIAL PROTEIN; CAGA PROTEIN; MUCIN; PHOSPHOLIPASE; PROTEIN DUPA; PROTEIN ICEA; PROTEIN JHP940; PROTEIN JHP947; PROTEIN JHP949; UNCLASSIFIED DRUG; VACUOLATING TOXIN; VIRULENCE FACTOR;

AMMONIA FORMATION; B CELL LYMPHOMA; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; CYTOTOXICITY; GASTRITIS; GASTROINTESTINAL MOTILITY; GENETIC VARIABILITY; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOMODULATION; INTESTINE FLORA; INTESTINE METAPLASIA; MOLECULAR MIMICRY; NONHUMAN; PATHOGENESIS; PEPTIC ULCER; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; STOMACH ADENOCARCINOMA; STOMACH EPITHELIUM; STOMACH LYMPHOMA; STOMACH MUCOSA; STOMACH PH; TISSUE INJURY; CLASSIFICATION; GENETICS; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI; NEGIBACTERIA;

GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; VIRULENCE FACTORS;

EID: 63849236851     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460913.4.2.223     Document Type: Review

References (176)

1. Kusters JG, van Vliet AH, Kuipers EJ: Pathogenesis of Helicobacter pylori infection. Clin. Microbiol. Rev. 19(3), 449-490 (2006).
2. Amieva MR, El-Omar EM: Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 134(1), 306-323 (2008).
3. Marshall BJ, Warren JR: Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1(8390), 1311-1315 (1984).
4. Blaser MJ, Atherton JC: Helicobacter pylori persistence: biology and disease. J. Clin. Invest. 113(3), 321-333 (2004).
5. Ernst PB, Gold BD: The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu. Rev. Microbiol. 54, 615-640 (2000).
6. Atherton JC: The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases. Annu. Rev. Pathol. 1, 63-96 (2006).
7. Modena JL, Acrani GO, Micas AF et al.: Correlation between Helicobacter pylori infection, gastric diseases and life habits among patients treated at a university hospital in southeast Brazil. Braz. J. Infect. Dis. 11(1), 89-95 (2007).
8. The EUROGAST Study Group: An international association between Helicobacter pylori infection and gastric cancer. Lancet 341(8857), 1359-1362 (1993).
9. Forman D, Sitas F, Newell DG et al.: Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China. Int. J. Cancer. 46(4), 608-611 (1990).
10. Fallone CA, Barkun AN, Gottke MU et al.: Association of Helicobacter pylori genotype with gastroesophageal reflux disease and other upper gastrointestinal diseases. Am. J. Gastroenterol. 95(3), 659-669 (2000).
11. Godoy AP, Ribeiro ML, Benvengo YH et al.: Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates. BMC Gastroenterol. 3, 20 (2003).
12. Linz B, Balloux F, Moodley Y et al.: An African origin for the intimate association between humans and Helicobacter pylori. Nature 445(7130), 915-918 (2007).
13. Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R: Helicobacter pylori virulence and genetic geography. Science 284(5418), 1328-1333 (1999).
14. Tomb JF, White O, Kerlavage AR et al.: The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388(6642), 539-547 (1997).
15. Alm RA, Ling LS, Moir DT et al.: Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 397(6715), 176-180 (1999).
16. Oh JD, Kling-Bäckhed H, Giannakis M et al.: The complete genome sequence of a chronic atrophic gastritis Helicobacter pylori strain: evolution during disease progression. Proc. Natl Acad. Sci. USA 103(26), 9999-10004 (2006).
17. Baltrus DA, Amieva MR, Covacci et al.: The complete genome sequence of Helicobacter pylori strain G27. J. Bacteriol. 191(1), 447-448 (2009).
18. Dunn BE, Campbell GP, Perez-Perez GI, Blaser MJ: Purification and characterization of urease from Helicobacter pylori. J. Biol. Chem. 265(16), 9464-9469 (1990).
19. Clyne M, Dolan B, Reeves EP: Bacterial factors that mediate colonization of the stomach and virulence of Helicobacter pylori. FEMS Microbiol. Lett. 268(2), 135-143 (2007).
20. Stingl K, De Reuse H: Staying alive overdosed: how does Helicobacter pylori control urease activity? Int. J. Med. Microbiol. 295(5), 307-315 (2005).
21. Scott DR, Marcus EA, Weeks DL, Sachs G: Mechanisms of acid resistance due to the urease system of Helicobacter pylori. Gastroenterology 123(1), 187-195 (2002).
22. Pflock M, Kennard S, Delany I, Scarlato V, Beier D: Acid-induced activation of the urease promoters is mediated directly by the ArsRS two-component system of Helicobacter pylori. Infect. Immun. 73(10), 6437-6445 (2005).
23. Sachs G, Weeks DL, Wen Y et al.: Acid acclimation by Helicobacter pylori. Physiology (Bethesda). 20, 429-438 (2005).
24. Skouloubris S, Labigne A, De Reuse H: The AmiE aliphatic amidase and AmiF formamidase of Helicobacter pylori: natural evolution of two enzyme paralogues. Mol. Microbiol. 40(3), 596-609 (2001).
25. McGee DJ, Zabaleta J, Viator RJ et al.: Purification and characterization of Helicobacter pylori arginase, RocF: unique features among the arginase superfamily. Eur. J. Biochem. 271(10), 1952-1962 (2004).
26. Pflock M, Kennard S, Finsterer N, Beier D: Acid-responsive gene regulation in the human pathogen Helicobacter pylori. J. Biotechnol. 126(1), 52-60 (2006).
27. Windle HJ, Fox A, Ni Eidhin D, Kelleher D: The thioredoxin system of Helicobacter pylori. J. Biol. Chem. 275(7), 5081-5089 (2000).
28. Eaton KA, Morgan DR, Krakowka S: Motility as a factor in the colonization of gnotobiotic piglets by Helicobacter pylori. J. Med. Microbiol. 37(2), 123-127 (1992).
29. Andersen-Nissen E, Smith KD, Strobe KL et al.: Evasion of Toll-like receptor 5 by flagellated bacteria. Proc. Natl Acad. Sci. USA 102(26), 9247-9252 (2005).
30. McGee DJ, Langford ML, Watson EL, Carter JE, Chen YT, Ottemann KM: Colonization and inflammation deficiencies in Mongolian gerbils infected by Helicobacter pylori chemotaxis mutants. Infect. Immun. 73(3), 1820-1827 (2005).
31. Croxen MA, Sisson G, Melano R, Hoffman PS: The Helicobacter pylori chemotaxis receptor TlpB (HP0103) is required for pH taxis and for colonization of the gastric mucosa. J. Bacteriol. 188(7), 2656-2665 (2006).
32. Alm RA, Bina J, Andrews BM et al.: Comparative genomics of Helicobacter pylori: analysis of the outer membrane protein families. Infect. Immun. 68(7), 4155-4168 (2000).
33. Odenbreit S: Adherence properties of Helicobacter pylori: impact on pathogenesis and adaptation to the host. Int. J. Med. Microbiol. 295(5), 317-324 (2005).
34. Boren T, Falk P, Roth KA, Larson G, Normark S: Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 262(5141), 1892-1895 (1993).
35. Ilver D, Arnqvist A, Ogren J et al.: Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 279(5349), 373-377 (1998).
36. Yamaoka Y: Roles of Helicobacter pylori BabA in gastroduodenal pathogenesis. World J. Gastroenterol. 14(27), 4265-4272 (2008).
37. Pride DT, Meinersmann RJ, Blaser MJ: Allelic variation within Helicobacter pylori babA and babB. Infect. Immun. 69(2), 1160-1171 (2001).
38. Aspholm-Hurtig M, Dailide G, Lahmann M et al.: Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin. Science 305(5683), 519-522 (2004).
39. Gerhard M, Lehn N, Neumayer N et al.: Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc. Natl Acad. Sci. USA 96(22), 12778-12783 (1999).
40. Prinz C, Schoniger M, Rad R et al.: Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation. Cancer Res. 61(5), 1903-1909 (2001).
41. Oliveira AG, Santos A, Guerra JB et al.: babA2- and cagA-positive Helicobacter pylori strains are associated with duodenal ulcer and gastric carcinoma in Brazil. J. Clin. Microbiol. 41(8), 3964-3966 (2003).
42. Erzin Y, Koksal V, Altun S et al.: Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA, babA2 genotypes and correlation with clinical outcome in Turkish patients with dyspepsia. Helicobacter 11(6), 574-580 (2006).
43. Gatti LL, Modena JL, Payao SL et al.: Prevalence of Helicobacter pylori cagA, iceA and babA2 alleles in Brazilian patients with upper gastrointestinal diseases. Acta Trop. 100(3), 232-240 (2006).
44. Olfat FO, Zheng Q, Oleastro M et al.: Correlation of the Helicobacter pylori adherence factor BabA with duodenal ulcer disease in four European countries. FEMS Immunol. Med. Microbiol. 44(2), 151-156 (2005).
45. Gatti LL, Fagundes e Souza EK, Leite KR et al.: cagA vacA alelles and babA2 genotypes of Helicobacter pylori associated with gastric disease in Brazilian adult patients. Diagn. Microbiol. Infect. Dis. 51(4), 231-235 (2005).
46. Mizushima T, Sugiyama T, Komatsu Y et al.: Clinical relevance of the babA2 genotype of Helicobacter pylori in Japanese clinical isolates. J. Clin. Microbiol. 39(7), 2463-2465 (2001).
47. Mattar R, dos Santos AF, Eisig JN et al.: No correlation of babA2 with vacA and cagA genotypes of Helicobacter pylori and grading of gastritis from peptic ulcer disease patients in Brazil. Helicobacter 10(6), 601-608 (2005).
48. Wen S, Velin D, Felley CP et al.: Expression of Helicobacter pylori virulence factors and associated expression profiles of inflammatory genes in the human gastric mucosa. Infect. Immun. 75(11), 5118-5126 (2007).
49. Mahdavi J, Sondén B, Hurtig M et al.: Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 297(5581), 573-578 (2002).
50. Walz A, Odenbreit S, Mahdavi J, Boren T, Ruhl S: Identification and characterization of binding properties of Helicobacter pylori by glycoconjugate arrays. Glycobiology 15(7), 700-708 (2005).
51. Unemo M, Aspholm-Hurtig M, Ilver D et al.: The sialic acid binding SabA adhesin of Helicobacter pylori is essential for nonopsonic activation of human neutrophils. J. Biol. Chem. 280(15), 15390-15397 (2005).
52. Aspholm M, Olfat FO, Norden J et al.: SabA is the H. pylori hemagglutinin and is polymorphic in binding to sialylated glycans. PLoS Pathog. 2(10), E110 (2006).
53. de Jonge R, Pot RG, Loffeld RJ et al.: The functional status of the Helicobacter pylori sabB adhesin gene as a putative marker for disease outcome. Helicobacter 9(2), 158-164 (2004).
54. Zanotti G, Papinutto E, Dundon W et al.: Structure of the neutrophil-activating protein from Helicobacter pylori. J. Mol. Biol. 323(1), 125-130 (2002).
55. Namavar F, Sparrius M, Veerman EC, Appelmelk BJ, Vandenbroucke-Grauls CM: Neutrophil-activating protein mediates adhesion of Helicobacter pylori to sulfated carbohydrates on high-molecular-weight salivary mucin. Infect. Immun. 66(2), 444-447 (1998).
56. Teneberg S, Miller-Podraza H, Lampert HC et al.: Carbohydrate binding specificity of the neutrophil-activating protein of Helicobacter pylori. J. Biol. Chem. 272(30), 19067-19071 (1997).
57. Dundon WG, Nishioka H, Polenghi A et al.: The neutrophil-activating protein of Helicobacter pylori. Int. J. Med. Microbiol. 291(6-7), 545-550 (2002).
58. Evans DJ Jr, Evans DG, Takemura T et al.: Characterization of a Helicobacter pylori neutrophil-activating protein. Infect. Immun. 63(6), 2213-2220 (1995).
59. Odenbreit S, Till M, Hofreuter D, Faller G, Haas R: Genetic and functional characterization of the alpAB gene locus essential for the adhesion of Helicobacter pylori to human gastric tissue. Mol. Microbiol. 31(5), 1537-1548 (1999).
60. de Jonge R, Durrani Z, Rijpkema SG, Kuipers EJ, van Vliet AH, Kusters JG: Role of the Helicobacter pylori outer-membrane proteins AlpA and AlpB in colonization of the guinea pig stomach. J. Med. Microbiol. 53(5), 375-379 (2004).
61. Peck B, Ortkamp M, Diehl KD, Hundt E, Knapp B: Conservation, localization and expression of HopZ, a protein involved in adhesion of Helicobacter pylori. Nucleic Acids Res. 27(16), 3325-3333 (1999).
62. Dossumbekova A, Prinz C, Mages J et al.: Helicobacter pylori HopH (OipA) and bacterial pathogenicity: genetic and functional genomic ana lysis of hopH gene polymorphisms. J. Infect. Dis. 194(10), 1346-1355 (2006).
63. Censini S, Lange C, Xiang Z et al.: cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl Acad. Sci. USA 93(25), 14648-14653 (1996).
64. Cascales E, Christie PJ: The versatile bacterial type IV secretion systems. Nat. Rev. Microbiol. 1(2), 137-149 (2003).
65. Christie PJ, Atmakuri K, Krishnamoorthy V, Jakubowski S, Cascales E: Biogenesis, architecture, and function of bacterial type IV secretion systems. Annu. Rev. Microbiol. 59, 451-485 (2005).
66. Backert S, Selbach M: Role of type IV secretion in Helicobacter pylori pathogenesis. Cell. Microbiol. 10(8), 1573-1581 (2008).
67. Cover TL, Dooley CP, Blaser MJ: Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect. Immun. 58(3), 603-610 (1990).
68. Covacci A, Censini S, Bugnoli M et al.: Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc. Natl Acad. Sci. USA 90(12), 5791-5795 (1993).
69. Proenca Modena JL, Lopes Sales AI, Olszanski Acrani G et al.: Association between Helicobacter pylori genotypes and gastric disorders in relation to the cag pathogenicity island. Diagn. Microbiol. Infect. Dis. 59(1), 7-16 (2007).
70. Ashour AA, Magalhães PP, Mendes EM et al.: Distribution of vacA genotypes in Helicobacter pylori strains isolated from Brazilian adult patients with gastritis, duodenal ulcer or gastric carcinoma. FEMS Immunol. Med. Microbiol. 33(3), 173-178 (2002).
71. Figueiredo C, Van Doorn LJ, Nogueira C et al.: Helicobacter pylori genotypes are associated with clinical outcome in Portuguese patients and show a high prevalence of infections with multiple strains. Scand. J. Gastroenterol. 36(2), 128-135 (2001).
72. Miehlke S, Kirsch C, Agha-Amiri K et al.: The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany. Int. J. Cancer 87(3), 322-327 (2000).
73. Rota CA, Pereira-Lima JC, Blaya C, Nardi NB: Consensus and variable region PCR ana lysis of Helicobacter pylori 3′ region of cagA gene in isolates from individuals with or without peptic ulcer. J. Clin. Microbiol. 39(2), 606-612 (2001).
74. Queiroz DM, Mendes EN, Carvalho AS et al.: Factors associated with Helicobacter pylori infection by a cagA-positive strain in children. J. Infect. Dis. 181(2), 626-630 (2000).
75. Queiroz DM, Mendes EN, Rocha GA et al.: cagA-positive Helicobacter pylori and risk for developing gastric carcinoma in Brazil. Int. J. Cancer 78(2), 135-139 (1998).
76. Rudi J, Kolb C, Maiwald M et al.: Diversity of Helicobacter pylori vacA and cagA genes and relationship to VacA and CagA protein expression, cytotoxin production, and associated diseases. J. Clin. Microbiol. 36(4), 944-948 (1998).
77. D'Elios MM, Manghetti M, De Carli M et al.: T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J. Immunol. 158(2), 962-967 (1997).
78. D'Elios MM, Manghetti M, Almerigogna F et al.: Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer. Eur. J. Immunol. 27(7), 1751-1755 (1997).
79. D'Elios MM, Amedei A, Del Prete G: Helicobacter pylori antigen-specific T-cell responses at gastric level in chronic gastritis, peptic ulcer, gastric cancer and low-grade mucosa-associated lymphoid tissue (MALT) lymphoma. Microbes Infect. 5(8), 723-730 (2003).
80. Segal ED, Cha J, Lo J, Falkow S, Tompkins LS: Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc. Natl Acad. Sci. USA 96(25), 14559-14564 (1999).
81. Stein M, Rappuoli R, Covacci A: Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host celltranslocation. Proc. Natl Acad. Sci. USA 97(3), 1263-1268 (2000).
82. Odenbreit S, Puls J, Sedlmaier B et al.: Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287(5457), 1497-1500 (2000).
83. Higashi H, Tsutsumi R, Fujita A et al.: Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc. Natl Acad. Sci. USA 99(22), 14428-14433 (2002).
84. Selbach M, Moese S, Hauck CR, Meyer TF, Backert S: Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. J. Biol. Chem. 277(9), 6775-6778 (2002).
85. Stein M, Bagnoli F, Halenbeck R et al.: c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol. Microbiol. 43(4), 971-980 (2002).
86. Tammer I, Brandt S, Hartig R, König W, Backert S: Activation of Abl by Helicobacter pylori: a novel kinase for CagA and crucial mediator of host cell scattering. Gastroenterology 132(4), 1309-1319 (2007).
87. Higashi H, Tsutsumi R, Muto S et al.: Shp-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 295(5555), 683-686 (2002).
88. Tsutsumi R, Higashi H, Higuchi M, Okada M, Hatakeyama M: Attenuation of Helicobacter pylori CagA x Shp-2 signaling by interaction between CagA and C-terminal Src kinase. J. Biol. Chem. 278(6), 3664-3670 (2003).
89. Suzuki M, Mimuro H, Suzuki T, Park M, Yamamoto T, Sasakawa C: Interaction of CagA with Crk plays an important role in Helicobacter pylori-induced loss of gastric epithelial cell adhesion. J. Exp. Med. 202(9), 1235-1247 (2005).
90. Ren S, Higashi H, Lu H, Azuma T, Hatakeyama M: Structural basis and functional consequence of Helicobacter pylori CagA multimerization in cells. J. Biol. Chem. 281(43), 32344-32352 (2006).
91. Higashi H, Nakaya A, Tsutsumi R et al.: Helicobacter pylori CagA induces Ras-independent morphogenetic response through Shp-2 recruitment and activation. J. Biol. Chem. 279(17), 17205-17216 (2004).
92. Tsutsumi R, Takahashi A, Azuma T, Hatakeyama M: Focal adhesion kinase is a substrate and downstream effector of Shp-2 complexed with Helicobacter pylori CagA. Mol. Cell Biol. 26(1), 261-276 (2006).
93. Selbach M, Moese S, Hurwitz R et al.: The Helicobacter pylori CagA protein induces cortactin dephosphorylation and actin rearrangement by c-Src inactivation. EMBO J. 22(3), 515-528 (2003).
94. Brandt S, Shafikhani S, Balachandran P et al.: Use of a novel coinfection system reveals a role for Rac1, H-Ras, and CrkII phosphorylation in Helicobacter pylori induced host cell actin cytoskeletal rearrangements. FEMS Immunol. Med. Microbiol. 50(2), 190-205 (2007).
95. Amieva MR, Vogelmann R, Covacci A, Tompkins LS, Nelson WJ, Falkow S: Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 300(5624), 1430-1434 (2003).
96. Saadat I, Higashi H, Obuse C et al.: Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 447(7142), 330-333 (2007).
97. Zeaiter Z, Cohen D, Músch A et al.: Analysis of detergent-resistant membranes of Helicobacter pylori infected gastric adenocarcinoma cells reveals a role for MARK2/Par1b in CagA-mediated disruption of cellular polarity. Cell. Microbiol. 10(3), 781-794 (2008).
98. Murata-Kamiya N, Kurashima Y, Teishikata Y et al.: Helicobacter pylori CagA interacts with E-cadherin and deregulates the β-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene 26(32), 4617-4626 (2007).
99. Mimuro H, Suzuki T, Tanaka J et al.: Grb2 is a key mediator of Helicobacter pylori CagA protein activities. Mol. Cell 10(4), 745-755 (2002).
100. Brandt S, Kwok T, Hartig R, König W, Backert S: NF-κB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc. Natl Acad. Sci. USA 102(26), 9300-9305 (2005).
101. Meyer-ter-Vehn T, Covacci A, Kist M, Pahl HL: Helicobacter pylori activates mitogen-activated protein kinase cascades and induces expression of the proto-oncogenes c-fos and c-jun. J. Biol. Chem. 275(21), 16064-16072 (2000).
102. Wang J, Brooks EG, Bamford KB et al.: Negative selection of T cells by Helicobacter pylori as a model for bacterial strain selection by immune evasion. J. Immunol. 167(2), 926-934 (2001).
103. Azuma T, Yamakawa A, Yamazaki S et al.: Correlation between variation of the 3′ region of the cagA gene in Helicobacter pylori and disease outcome in Japan. J. Infect. Dis. 186(11), 1621-1630 (2002).
104. Owen RJ, Sharp S, Lawson AJ et al.: Investigation of the biological relevance of Helicobacter pylori cagE locus diversity, presence of CagA tyrosine phosphorylation motifs and vacuolating cytotoxin genotype on IL-8 induction in gastric epithelial cells. FEMS Immunol. Med. Microbiol. 36(3), 135-140 (2003).
105. Argent RH, Kidd M, Owen RJ et al.: Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. Gastroenterology 127(2), 514-523 (2004).
106. Tummuru MK, Sharma SA, Blaser MJ: Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol. Microbiol. 18(5), 867-876 (1995).
107. Fischer W, Puls J, Buhrdorf R et al.: Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol. Microbiol. 42(5), 1337-1348 (2001).
108. Ikenoue T, Maeda S, Ogura K et al.: Determination of Helicobacter pylori virulence by simple gene ana lysis of the cag pathogenicity island. Clin. Diagn. Lab. Immunol. 8(1), 181-186 (2001).
109. Mattar R, Marques SB, Monteiro Mdo S et al.: Helicobacter pylori cag pathogenicity island genes: clinical relevance for peptic ulcer disease development in Brazil. J. Med. Microbiol. 56(1), 9-14 (2007).
110. Pacheco AR, Proenca-Modena JL, Sales AIL et al.: Involvement of the Helicobacter pylori plasticity region and cag pathogenicity island (cagPAI) genes in the development of gastroduodenal diseases Eur. J. Clin. Microbiol. Infect. Dis. 27(11), 1053-1059 (2008).
111. Glocker E, Lange C, Covacci A, Bereswill S, Kist M, Pahl HL: Proteins encoded by the cag pathogenicity island of Helicobacter pylori are required for NF-κB activation. Infect. Immun. 66(5), 2346-2348 (1998).
112. Viala J, Chaput C, Boneca IG et al.: Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol. 5(11), 1166-1174 (2004).
113. Kersulyte D, Chalkauskas H, Berg DE: Emergence of recombinant strains of Helicobacter pylori during human infection. Mol. Microbiol. 31(1), 31-43 (1999).
114. Figura N, Vindigni C, Covacci A et al.: cagA positive and negative Helicobacter pylori strains are simultaneously present in the stomach of most patients with non-ulcer dyspepsia: relevance to histological damage. Gut 42(6), 772-778 (1998).
115. Sozzi M, Tomasini ML, Vindigni C et al.: Heterogeneity of cag genotypes and clinical outcome of Helicobacter pylori infection. J. Lab. Clin. Med. 146(5), 262-270 (2005).
116. Tomasini ML, Zanussi S, Sozzi M et al.: Heterogeneity of cag genotypes in Helicobacter pylori isolates from human biopsy specimens. J. Clin. Microbiol. 41(3), 976-980 (2003).
117. Matteo MJ, Granados G, Pérez CV et al.: Helicobacter pylori cag pathogenicity island genotype diversity within the gastric niche of a single host. J. Med. Microbiol. 56(Pt 5), 664-669 (2007).
118. Cover TL, Blaser MJ: Purification and characterization of the vacuolating toxin from Helicobacter pylori. J. Biol. Chem. 267(15), 10570-10575 (1992).
119. Radosz-Komoniewska H, Bek T, Jozwiak J, Martirosian G: Pathogenicity of Helicobacter pylori infection. Clin. Microbiol. Infect. 11(8), 602-610 (2005).
120. Fitchen N, Letley DP, O'Shea P et al.: All subtypes of the cytotoxin VacA adsorb to the surface of Helicobacter pylori postsecretion. J. Med. Microbiol. 54(7), 621-630 (2005).
121. Ilver D, Barone S, Mercati D, Lupetti P, Telford JL: Helicobacter pylori toxin VacA is transferred to host cells via a novel contact dependent mechanism. Cell. Microbiol. 6(2), 167-174 (2004).
122. Reyrat JM, Rappuoli R, Telford JL: A structural overview of the Helicobacter cytotoxin. Int. J. Med. Microbiol. 290(4-5), 375-379 (2000).
123. Atherton JC, Cao P, Peek RM Jr et al.: Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J. Biol. Chem. 270(30), 17771-17777 (1995).
124. Ogura K, Maeda S, Nakao M et al.: Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil. J. Exp. Med. 192(11), 1601-1610 (2000).
125. Salama NR, Otto G, Tompkins L, Falkow S: Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mouse model of infection. Infect. Immun. 69(2), 730-736 (2001).
126. Rhead JL, Letley DP, Mohammadi M et al.: A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology 133(3), 926-936 (2007).
127. Letley DP, Lastovica A, Louw JA, Hawkey CJ, Atherton JC: Allelic diversity of the Helicobacter pylori vacuolating cytotoxin gene in South Africa: rarity of the vacA s1a genotype and natural occurrence of an s2/m1 allele. J. Clin. Microbiol. 37(4), 1203-1205 (1999).
128. Kidd M, Lastovica AJ, Atherton JC, Louw JA: Heterogeneity in the Helicobacter pylori vacA and cagA genes: association with gastroduodenal disease in South Africa? Gut 45(4), 499-502 (1999).
129. De Gusmão VR, Nogueira Mendes E, De Magalhães Queiroz DM et al.: vacA genotypes in Helicobacter pylori strains isolated from children with and without duodenal ulcer in Brazil. J. Clin. Microbiol. 38(8), 2853-2857 (2000).
130. Letley DP, Rhead JL, Twells RJ, Dove B, Atherton JC: Determinants of non-toxicity in the gastric pathogen Helicobacter pylori. J. Biol. Chem. 278(29), 26734-26741 (2003).
131. Basso D, Zambon CF, Letley DP et al.: Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 135(1), 91-99 (2008).
132. Cover TL, Blanke SR: Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat. Rev. Microbiol. 3(4), 320-332 (2005).
133. Czajkowsky DM, Iwamoto H, Cover TL, Shao Z: The vacuolating toxin from Helicobacter pylori forms hexameric pores in lipid bilayers at low pH. Proc. Natl Acad. Sci. USA 96(5), 2001-2006 (1999).
134. Szabo I, Brutsche S, Tombola F et al.: Formation of anion-selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity. EMBO. J. 18(20), 5517-5527 (1999).
135. Tombola F, Morbiato L, del Giudice G et al.: The Helicobacter pylori VacA toxin is a urea permease that promotes urea diffusion across epithelia. J. Clin. Invest. 108(5), 929-937 (2001).
136. Papini E, de Bernard M, Milia E et al.: Cellular vacuoles induced by Helicobacter pylori originate from late endosomal compartments. Proc. Natl Acad. Sci. USA 91(21), 9720-9724 (1994).
137. Papini E, Satin B, Norais N et al.: Selective increase of the permeability of polarized epithelial cell monolayers by Helicobacter pylori vacuolating toxin. J. Clin. Invest. 102(4), 813-820 (1998).
138. Cover TL, Krishna US, Israel DA, Peek RM Jr: Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin. Cancer Res. 63(5), 951-957 (2003).
139. Neu B, Randlkofer P, Neuhofer M et al.: Helicobacter pylori induces apoptosis of rat gastric parietal cells. Am. J. Physiol. Gastrointest. Liver Physiol. 283(2), G309-G318 (2002).
140. Molinari M, Salio M, Galli C et al.: Selective inhibition of Ii-dependent antigen presentation by Helicobacter pylori toxin VacA. J. Exp. Med. 187(1), 135-140 (1998).
141. Gebert B, Fischer W, Weiss E, Hoffmann R Haas R: Helicobacter pylori vacuolating cytotoxin inhibits T-lymphocyte activation. Science 301(5636), 1099-1102 (2003).
142. Zheng PY, Jones NL: Helicobacter pylori strains expressing the vacuolating cytotoxin interrupt phagosome maturation in macrophages by recruiting and retaining TACO (coronin 1) protein. Cell. Microbiol. 5(1), 25-40 (2003).
143. Peek RM Jr, Thompson SA, Donahue JP et al.: Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome. Proc. Assoc. Am. Physicians 110(6), 531-544 (1998).
144. Nishiya D, Shimoyama T, Fukuda S et al.: Evaluation of the clinical relevance of the iceA1 gene in patients with Helicobacter pylori infection in Japan. Scand. J. Gastroenterol. 35(1), 36-39 (2000).
145. Yamaoka Y, Kodama T, Gutierrez O et al.: Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J. Clin. Microbiol. 37(7), 2274-2279 (1999).
146. Ashour AA, Collares GB, Mendes EM et al.: iceA genotypes of Helicobacter pylori strains isolated from Brazilian children and adults. J. Clin. Microbiol. 39(5), 1746-1750 (2001).
147. Xu Q, Blaser MJ: Promoters of the CATG-specific methyltransferase gene hpyIM differ between iceA1 and iceA2 Helicobacter pylori strains. J. Bacteriol. 183(13), 3875-3884 (2001).
148. Xu Q, Morgan RD, Roberts RJ et al.: Functional ana lysis of iceA1, a CATG-recognizing restriction endonuclease gene in Helicobacter pylori. Nucleic Acids Res. 30(17), 3839-3847 (2002).
149. Heithoff DM, Sinsheimer RL, Low DA, Mahan MJ: An essential role for DNA adenine methylation in bacterial virulence. Science 284(5416), 967-970 (1999).
150. Ge Z, Taylor DE: Contributions of genome sequencing to understanding the biology of Helicobacter pylori. Annu. Rev. Microbiol. 53, 353-387 (1999).
151. Occhialini A, Marais A, Alm R et al.: Distribution of open reading frames of plasticity region of strain J99 in Helicobacter pylori strains isolated from gastric carcinoma and gastritis patients in Costa Rica. Infect. Immun. 68(11), 6240-6249 (2000).
152. Santos A, Queiroz DM, Menard A et al.: New pathogenicity marker found in the plasticity region of the Helicobacter pylori genome. J. Clin. Microbiol. 41(4), 1651-1655 (2003).
153. de Jonge R, Kuipers EJ, Langeveld SC et al.: The Helicobacter pylori plasticity region locus jhp0947-jhp0949 is associated with duodenal ulcer disease and interleukin-12 production in monocyte cells. FEMS Immunol. Med. Microbiol. 41(2), 161-167 (2004).
154. Lu H, Hsu PI, Graham DY, Yamaoka Y: Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology 128(4), 833-848 (2005).
155. Arachchi HS, Kalra V, Lal B et al.: Prevalence of duodenal ulcer-promoting gene (dupA) of Helicobacter pylori in patients with duodenal ulcer in North Indian population. Helicobacter 12(6), 591-597 (2007).
156. Gomes LI, Rocha GA, Rocha AM et al.: Lack of association between Helicobacter pylori infection with dupA-positive strains and gastroduodenal diseases in Brazilian patients. Int. J. Med. Microbiol. 298(3-4), 223-230 (2008).
157. Douraghi M, Mohammadi M, Oghalaie A et al.: dupA as a risk determinant in Helicobacter pylori infection. J. Med. Microbiol. 57(Pt 5), 554-562 (2008).
158. Argent RH, Burette A, Miendje Deyi VY, Atherton JC: The presence of dupA in Helicobacter pylori is not significantly associated with duodenal ulceration in Belgium, South Africa, China, or North America. Clin. Infect. Dis. 45(9), 1204-1206 (2007).
159. Yamaoka Y: Roles of the plasticity regions of Helicobacter pylori in gastroduodenal pathogenesis. J. Med. Microbiol. 57 (Pt 5), 545-553 (2008).
160. +-adenosine triphosphatase in human gastric autoimmunity. J. Exp. Med. 198(8), 1147-1156 (2003).
161. Muotiala A, Helander IM, Pyhala L, Kosunen TU, Moran AP: Low biological activity of Helicobacter pylori lipopolysaccharide. Infect. Immun. 60(4), 1714-1716 (1992).
162. Monteiro MA, Chan KH, Rasko DA et al.: Simultaneous expression of type 1 and type 2 Lewis blood group antigens by Helicobacter pylori lipopolysaccharides. Molecular mimicry between H. pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms. J. Biol. Chem. 273(19), 11533-11543 (1998).
163. Appelmelk BJ, Monteiro MA, Martin SL, Moran AP, Vandenbroucke-Grauls CM: Why Helicobacter pylori has Lewis antigens. Trends Microbiol. 8(12), 565-570 (2000).
164. Moran AP: Relevance of fucosylation and Lewis antigen expression in the bacterial gastroduodenal pathogen Helicobacter pylori. Carbohydr. Res. 343(12), 1952-1965 (2008).
165. Mahdavi J, Boren T, Vandenbroucke-Grauls C, Appelmelk BJ: Limited role of lipopolysaccharide Lewis antigens in adherence of Helicobacter pylori to the human gastric epithelium. Infect. Immun. 71(5), 2876-2880 (2003).
166. D'Elios MM, Amedei A, Cappon A et al.: The neutrophil-activating protein of Helicobacter pylori (HP-NAP) as an immune modulating agent. FEMS Immunol. Med. Microbiol. 50(2), 157-164 (2007).
167. Montemurro P, Nishioka H, Dundon WG et al.: The neutrophil-activating protein of Helicobacter pylori is a potent stimulant of mast cells. Eur. J. Immunol. 32(3), 671-676 (2002).
168. Amedei A, Cappon A, Codolo G et al.: The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses. J. Clin. Invest. 116(4), 1092-1101 (2006).
169. Kang J, Blaser MJ: Bacterial populations as perfect gases: genomic integrity and diversification tensions in Helicobacter pylori. Nat. Rev. Microbiol. 4(11), 826-836 (2006).
170. Suerbaum S, Josenhans C: Helicobacter pylori evolution and phenotypic diversification in a changing host. Nat. Rev. Microbiol. 5(6), 441-452 (2007).
171. Gressmann H, Linz B, Ghai R et al.: Gain and loss of multiple genes during the evolution of Helicobacter pylori. PLoS Genet. 1(4), E43 (2005).
172. Covacci A, Rappuoli R: Helicobacter pylori: molecular evolution of a bacterial quasispecies. Curr. Opin Microbiol. 1(1), 96-102 (1998).
173. Alm RA, Trust TJ: Analysis of the genetic diversity of Helicobacter pylori: the tale of two genomes. J. Mol. Med. 77(12), 834-846 (1999).
174. Salaün L, Linz B, Suerbaum S, Saunders NJ: The diversity within an expanded and redefined repertoire of phase-variable genes in Helicobacter pylori. Microbiology 150(4), 817-830 (2004).
175. Suerbaum S, Smith JM, Bapumia K et al.: Free recombination within Helicobacter pylori. Proc. Natl Acad. Sci. USA 95(21), 12619-12624 (1998).
176. Dhar AK, Soni RK, Das BK, Mukhopadhyay G: Molecular mechanism of action of major Helicobacter pylori virulence factors. Mol. Cell. Biochem. 253(1-2), 207-215 (2003).